Withdrawal from anabolic steroids.
Brower
K J
KJ
University of Michigan Medical School, Ann Arbor.
D045930:Anabolic Agents / Q000009:adverse effects*; D000700:Analgesics / Q000627:therapeutic use; D000928:Antidepressive Agents / Q000627:therapeutic use; D006063:Chorionic Gonadotropin / Q000627:therapeutic use; D003000:Clonidine / Q000627:therapeutic use; D003376:Counseling; D007987:Gonadotropin-Releasing Hormone / Q000627:therapeutic use; D006801:Humans; D007030:Hypothalamo-Hypophyseal System / Q000187:drug effects; D008297:Male; D011613:Psychotherapy; D013375:Substance Withdrawal Syndrome / Q000517:prevention & control* / Q000523:psychology; D013737:Testis / Q000187:drug effects; D013739:Testosterone / Q000031:analogs & derivatives / Q000627:therapeutic use
D045930:Anabolic Agents; D000700:Analgesics; D000928:Antidepressive Agents; D006063:Chorionic Gonadotropin; D007987:Gonadotropin-Releasing Hormone; D013739:Testosterone; C004648:testosterone enanthate; D003000:Clonidine